In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all educational programs.
The following faculty have disclosed:
Nikhil I. Khushalani, MD, faculty for this educational event, is a contracted researcher for BMS, Merck, Celgene, Novartis, GSK, HUYA, Regeneron, Replimune, and Modulation Therapeutics; holds ownership interest in Bellicum, Amarin, and Ascensus Surgical; and receives consulting fees from AstraZeneca, BMS, Castle Biosciences, Genzyme, Incyte, Instill Bio, Iovance, Jounce Therapeutics, Merck, Nektar, Novartis, and Regeneron.
Tara C. Mitchell, MD, faculty for this educational event, is a contracted researcher for BMS, Merck, and Incyte; and receives consulting fees from BMS, GigaGen, Merck, Pliant, and Pfizer.